Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents

Early Phase 1

Completed

Conditions: NAFLD

Interventions: Drug: somatropin

First Posted Date: 2016-04-01

Last Posted Date: 2022-09-07

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 24

Registration Number: NCT02726542

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma

Phase 1

Withdrawn

Conditions: Lymphoma

Interventions: Procedure: Allogeneic stem cell transplantation
Drug: Fludarabine
Drug: Thiotepa
Drug: Methotrexate

First Posted Date: 2016-03-31

Last Posted Date: 2017-03-22

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT02724904

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States

Impact of Infant Formula on Resolution of Cow's Milk Allergy

Phase 2

Terminated

Conditions: Milk Allergy

Interventions: Dietary Supplement: Extensively Hydrolyzed Casein Formula
Dietary Supplement: Amino Acid Formula
Dietary Supplement: Lactobacillus GG

First Posted Date: 2016-03-25

Last Posted Date: 2018-07-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 49

Registration Number: NCT02719405

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Woburn Pediatric Associates, Woburn, Massachusetts, United States

A Pilot Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Bipolar Depression

Phase 4

Suspended

Conditions: Bipolar Depression
Bipolar Disorder

Interventions: Dietary Supplement: N-acetylcysteine
Drug: Minocycline
Other: Placebo

First Posted Date: 2016-03-25

Last Posted Date: 2025-05-18

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 40

Registration Number: NCT02719392

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma

Phase 2

Active, not recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Elotuzumab
Drug: Pomalidomide
Drug: Bortezomib
Drug: Dexamethasone

First Posted Date: 2016-03-24

Last Posted Date: 2024-04-16

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 52

Registration Number: NCT02718833

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Newton-Wellesley Hospital, Newton, Massachusetts, United States

and more 3 locations

Translational Investigation of Gestational Environment on Neurobehavioral Function in Children

Completed

Conditions: Major Depressive Disorder

First Posted Date: 2016-03-22

Last Posted Date: 2020-03-16

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 95

Registration Number: NCT02715778

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Boston Children's Hospital, Boston, Massachusetts, United States

The Effect of Naloxegol on Refractory Constipation in the Intensive Care Unit

Phase 3

Withdrawn

Conditions: Constipation
Critical Illness

Interventions: Drug: Polyethylene glycol
Drug: naloxegol

First Posted Date: 2016-03-10

Last Posted Date: 2021-05-05

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT02705378

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Patient Navigation for Lung Screening at MGH Community Health Centers

Not Applicable

Completed

Conditions: Lung Cancer

Interventions: Other: Patient Navigation
Other: Usual Care

First Posted Date: 2016-03-10

Last Posted Date: 2018-01-05

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 1200

Registration Number: NCT02705365

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

The iLet Introduction Study: A Feasibility Study of the iLet, a Fully Integrated Bihormonal Bionic Pancreas

Not Applicable

Terminated

Conditions: Diabetes Mellitus Type 1

Interventions: Device: iPhone bionic pancreas
Device: iLet bionic pancreas
Device: Contact Detach infusion set
Device: iLet infusion set
Drug: Lilly glucagon
Drug: Xeris Xerisol glucagon

First Posted Date: 2016-03-08

Last Posted Date: 2019-11-18

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 20

Registration Number: NCT02701257

Locations: 🇺🇸
MGH Diabetes Research Center, Boston, Massachusetts, United States

A Video Decision Support Tool to Assist Elderly Patients in ESRD Treatment Decision-making

Not Applicable

Completed

Conditions: Decision-making
Chronic Kidney Disease

Interventions: Other: End-stage renal disease treatment options

First Posted Date: 2016-03-04

Last Posted Date: 2019-10-07

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 100

Registration Number: NCT02698722

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy